Although the use of factor Xa (FXa) inhibitors has increased substantially over the past decade, there are limited data on characteristics and outcomes of FXa inhibitor–associated intracerebral hemorrhage (ICH). The gene discussed is F10; the disease is intracerebral hemorrhage.